Overview
Streptococcal pleurisy, often secondary to streptococcal tonsillopharyngitis, involves inflammation of the pleura due to group A Streptococcus (GAS) infection. Primary management focuses on treating the underlying pharyngeal infection to prevent complications like pleural effusion or empyema.Diagnosis
Clinical Presentation: Sore throat, fever, tonsillar exudates, and sometimes lymphadenopathy 6.
Laboratory Tests: Rapid antigen detection tests (RADT) for GAS are sensitive (79%-88%) and specific (90%-96%), aiding accurate diagnosis 6.
Culture: Throat cultures confirm GAS infection, essential for ruling out false negatives from RADT 6.Management
First-Line Treatment: Penicillin V or amoxicillin are commonly used.
- Penicillin V: 10 days at 10 mg/kg/dose QID (max 250 mg/dose) 25.
- Amoxicillin: Once-daily modified-release formulation for 7 days shows comparable efficacy to 10-day regimens 2.
Alternative Antibiotics: Cefprozil for 10 days demonstrated high clinical cure (96.6%) and bacteriological eradication (94.29%) rates 4.
Duration: Shorter courses (7 days) may be effective but efficacy varies; longer courses (10 days) traditionally recommended 12.Special Populations
Pediatrics: Shorter antibiotic courses (7 days) are likely effective but efficacy rates vary; careful monitoring advised 12.
Age Considerations: Younger children (<6 years) may have higher rates of treatment failure with penicillin V 5.Key Recommendations
Utilize rapid antigen detection tests for accurate diagnosis of streptococcal tonsillopharyngitis (Evidence: Strong 6).
For pediatric patients, a 7-day course of amoxicillin may be considered as effective as a 10-day regimen, though efficacy varies (Evidence: Moderate 12).
In cases where shorter courses are used, particularly in younger children, close monitoring for treatment failure is essential (Evidence: Expert opinion).
For confirmed streptococcal tonsillopharyngitis, initiate treatment with penicillin V for 10 days or an equivalent dose of amoxicillin, considering patient-specific factors (Evidence: Moderate 25).
In settings with penicillin resistance concerns or patient intolerance, cefprozil for 10 days offers high efficacy and tolerability (Evidence: Moderate 4).References
1 Rojas-Ramírez C, Kramer-Urrutia T, Cifuentes L. Is a short-course antibiotic treatment effective for streptococcal tonsillopharyngitis in children?. Medwave 2017. link
2 Pichichero ME, Casey JR, Block SL, Guttendorf R, Flanner H, Markowitz D et al.. Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children. Antimicrobial agents and chemotherapy 2008. link
3 Blumer JL, Reed MD, Kaplan EL, Drusano GL. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Pediatrics 2005. link
4 Gupta N, Mukherjee A, Moharana AK. Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients. Indian journal of pediatrics 2004. link
5 Ovetchkine P, Levy C, de la Rocque F, Boucherat M, Bingen E, Cohen R. Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V. European journal of pediatrics 2002. link
6 Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Annals of emergency medicine 1995. link70300-4)